Evidence map›Paper›PMID 42611819›Full record

ArticlePsychotherapy and psychosomatics2026

Toward Personalized Psychotherapy in Anorexia Nervosa: Evidence from Long-Term Moderator Analyses of the ANTOP Study.

Beate Wild, Hans-Christoph Friederich, Katrin Elisabeth Giel, Wolfgang Herzog, Gaby Resmark, Dieter Schellberg, Florian Junne, Martin Teufel, Martina de Zwaan, Andreas Dinkel and 10 more

Abstract read
In one paragraph

Article in Psychotherapy and psychosomatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Beate WildDepartment of General Internal Medicine, Psychosomatics and Psychotherapy, University of Heidelberg, Heidelberg, Germany, beate.wild@med.uni-heidelberg.de.
Hans-Christoph FriederichDepartment of General Internal Medicine, Psychosomatics and Psychotherapy, University of Heidelberg, Heidelberg, Germany.
Katrin Elisabeth GielDepartment of Psychosomatic Medicine and Psychotherapy, University of Tübingen, Tübingen, Germany.
Wolfgang HerzogDepartment of General Internal Medicine, Psychosomatics and Psychotherapy, University of Heidelberg, Heidelberg, Germany.
Gaby ResmarkDepartment of Psychosomatic Medicine and Psychotherapy, University of Tübingen, Tübingen, Germany.
Dieter SchellbergDepartment of General Internal Medicine, Psychosomatics and Psychotherapy, University of Heidelberg, Heidelberg, Germany.
Florian Junne
Martin TeufelDepartment of Psychosomatic Medicine and Psychotherapy, University of Tübingen, Tübingen, Germany.
Martina de ZwaanDepartment of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hannover, Germany.
Andreas DinkelDepartment of Psychosomatic Medicine and Psychotherapy, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Stephan HerpertzDepartment of Psychosomatic Medicine and Psychotherapy, University of Bochum, Bochum, Germany.
Markus BurgmerDepartment of Psychosomatic Medicine and Psychotherapy, LWL-Hospital Münster and University of Münster, Münster, Germany.
Bernd LöweDepartment of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Almut ZeeckDepartment of Psychosomatic Medicine und Psychotherapy, Center for Mental Health, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Jörn von WietersheimDepartment of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.
Sefik TagayKöln-University of Applied Sciences, Köln, Germany.
Carmen Schade-BrittingerCoordination Center for Clinical Trials (KKS), University of Marburg, Marburg, Germany.
Henning SchauenburgDepartment of General Internal Medicine, Psychosomatics and Psychotherapy, University of Heidelberg, Heidelberg, Germany.
Ulrike SchmidtDepartment of Psychological Medicine, King's College London, London, UK.
Stephan ZipfelDepartment of Psychosomatic Medicine and Psychotherapy, University of Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Anorexia Nervosa Treatment of Outpatients (ANTOP) randomized controlled trial involved 242 adult patients with anorexia nervosa. Patients from 10 German university hospitals were randomly allocated to 10 months of treatment with focal psychodynamic therapy (FPT), enhanced cognitive behaviour therapy (CBT-E), or optimized treatment as usual (TAU-O). At the end of treatment and follow-up no significant body mass index (BMI) differences between groups were reported. The present study is an explorative, secondary analysis of moderators of weight gain for FPT and CBT-E.

methodsN = 160 patients - randomized to FPT and CBT-E - were included in the analysis. Moderator analysis was conducted by using a mixed model approach for repeated measures (MMRM). The outcome variable was BMI at the last follow-up T5 (mean time of 5.96 years after the beginning of the study).

resultsLow depression severity and high mental quality of life (QoL) at baseline moderated the outcome in favour of CBT-E, whereas high depression severity and low mental QoL was associated with a better outcome in FPT. Sensitivity analyses to predict BMI at earlier time points T1-T4 produced the same results. The direction of the moderator effects was the same for CBT-E and FPT across all time points. Graphical visualization confirms that there is a wide range where both treatments perform similarly, while CBT or FPT perform differently in the extreme ranges of these two variables.

conclusionThese findings suggest that baseline psychological burden may inform the selection of psychotherapy modality in anorexia nervosa, supporting a move toward personalized, mechanism-informed treatment allocation.

Indexed as

Anorexia nervosaCognitive behavioural therapyModeratorsPsychodynamic therapyRandomized controlled trial

Identifiers

PMID42611819
PMCPMC13641741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.